RDUS News
Archived Headlines
- Bone loss biotech Radius Health refiles terms; slashes market cap by 43% 06/02/14
- Two US IPOs planned for the week of Jun 2 06/02/14
- Bone loss biotech Radius Health revives IPO filing again, removes original terms 05/21/14
- Radius Health postpones $75 million IPO 05/09/14
- 9 US IPOs planned for the week of May 5 05/05/14
See more
Zosano Pharma increases proposed IPO deal size by 43%; now expected to raise $47 million
Zosano Pharma, which is developing a transdermal formulation of an approved osteoporosis treatment, increased the proposed deal size for its upcoming IPO on Monday. The Fremont, CA-based company now plans to raise $47 million by offering 4.3 million shares...read more
Osteoporosis biotech Zosano Pharma sets terms for $33 million IPO
Zosano Pharma, which is developing a transdermal formulation of an approved osteoporosis treatment, announced terms for its IPO on Friday. The Fremont, CA-based company plans to raise $33 million by offering 3 million shares at a price range of $10 to $12. At...read more
US IPO Pricing Recap: Arista kicks off a heating IPO market in June
Arista Networks (ANET) and Radius Health (RDUS) began trading on Friday as the first two initial public offerings of an increasingly packed June IPO calendar. While ...read more
Radius Health prices IPO at $8 as expected
Radius Health, which is developing treatments to restore bone density in osteoporosis patients, raised $52 million by offering 6.5 million shares at $8, the revised IPO price. The company originally filed to offer 5.0 million shares at $14 to $16 per share...read more